ZILBRYSQ
Live / Registered — Registered (as of 13 Feb 2024)
What this means for you
Registered since 13 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90286947
- Registration number
- 7305051
- Mark type
- Word mark
- Filed
- 29 Oct 2020
- Published for opposition
- 04 May 2021
- Registered
- 13 Feb 2024
- Attorney of record
- Kumiko Ide
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, for human use, for the prevention and treatment of myasthenia gravis
Owner
- UCB HOLDINGS, INC., SMYRNA, GA, US
- Ra Pharmaceuticals, Inc., Cambridge, MA, US
- Ra Pharmaceuticals, Inc., Cambridge, MA, US
- Ra Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 24 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 10 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Jan 2024 — USE AMENDMENT FILED
- 08 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 29 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Nov 2023 — SOU EXTENSION 5 GRANTED
- 16 Nov 2023 — SOU EXTENSION 5 FILED
- 28 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 04 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2023 — SOU EXTENSION 4 GRANTED